-
Loading metrics
The Efficacy of Natalizumab versus Fingolimod for Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review, Indirect Evidence from Randomized Placebo-Controlled Trials and Meta-Analysis of Observational Head-to-Head Trials
- Georgios Tsivgoulis,
- Aristeidis H. Katsanos,
- Dimitris Mavridis,
- Nikolaos Grigoriadis,
- Efthymios Dardiotis,
- Ioannis Heliopoulos,
- Panagiotis Papathanasopoulos,
- Theodoros Karapanayiotides,
- Constantinos Kilidireas,
- Georgios M. Hadjigeorgiou
x
- Published: September 29, 2016
- https://doi.org/10.1371/journal.pone.0163296